Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx...

FDA Drug Recall #D-0472-2025 — Class II — May 29, 2025

Recall Summary

Recall Number D-0472-2025
Classification Class II — Moderate risk
Date Initiated May 29, 2025
Status Ongoing
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Eugia US LLC
Location East Windsor, NJ
Product Type Drugs
Quantity 48,000 vials

Product Description

Gentamicin Injection, USP, (PEDIATRIC), 20 mg per 2 mL (10 mg per mL*), 2 mL Single-Dose Vial, Rx Only, Mfd. in India for: Eugia US LLC, E. Windsor, NJ, 08520 Vial- NDC 55150-401-01, Carton NDC 55150-401-25

Reason for Recall

Failed Stability Specifications: Out of specification results for the Color Absorbance test during 12 Month sample analysis.

Distribution Pattern

Nationwide in the USA

Lot / Code Information

Batch 3GT23006, 3GT23007, 3GT23008, Exp Date: November, 30, 2025

Other Recalls from Eugia US LLC

Recall # Classification Product Date
D-0389-2025 Class II Tirofiban Hydrochloride Injection 5 mg/100 mL (... Apr 21, 2025
D-0390-2025 Class II Tirofiban Hydrochloride Injection 12.5 mg/250 m... Apr 21, 2025
D-0363-2025 Class II Testosterone Cypionate Injection, USP, CIII, 20... Apr 10, 2025
D-0186-2025 Class II Progesterone Injection USP, 500mg per 10 mL (50... Dec 27, 2024
D-0185-2025 Class II medroxyPROGESTERone Acetate Injectable Suspensi... Dec 18, 2024

Frequently Asked Questions

Stop taking the medication and contact your pharmacist or doctor immediately. For Class I recalls, this is urgent. For Class II or III recalls, consult your doctor before stopping — abruptly discontinuing certain medications (blood pressure drugs, antidepressants, diabetes medications) can be more harmful than continuing while arranging a replacement. Check whether the recall applies to your specific lot number and expiration date. Return the product to your pharmacy and report any adverse effects to FDA MedWatch at 1-800-FDA-1088.

Not necessarily. Many drug recalls are initiated because of quality system failures or test results that suggest a product might not meet specifications — even if no patients have reported harm. The FDA uses a precautionary approach: if there is reason to believe quality standards were not met, a recall is required regardless of whether adverse effects have been reported. Class I recalls typically involve a reasonable probability of harm; Class II recalls may cause temporary health issues; Class III recalls are for products unlikely to cause adverse health consequences but that still violate regulations.

Pharmacies typically receive recall notices directly from drug wholesalers and manufacturers within days of the recall being announced. Your pharmacist can look up whether any product in your prescription history matches a recalled lot number. For current recalls, the FDA publishes updates at FDA.gov/safety/recalls-market-withdrawals-safety-alerts and sends MedWatch email alerts for significant drug safety issues. You can sign up for MedWatch alerts at FDA.gov. Most major pharmacy chains also have their own recall notification systems that automatically alert pharmacists when a recalled product is in their inventory.

What Should You Do?

Stop using this medication if affected by this recall. Contact your pharmacist or prescribing doctor immediately for guidance. Do not flush medications — use a drug take-back program.